15 July 2021: Database Analysis
Epithelial Splicing Regulatory Protein 1 Is Overexpressed in Breast Cancer and Predicts Poor Prognosis for Breast Cancer Patients
Xinyu Liu 1ABCE , Qiangshan Wang 2B , Siqi Song 1B , Manman Feng 1B , Xiaoya Wang 1B , Ling Li 1B , Ying Liu 13B* , Chunying Shi 1BEG*DOI: 10.12659/MSM.931102
Med Sci Monit 2021; 27:e931102
Figure 6 Analysis of ESRP1 prognostic value in breast cancer. The association of ESRP1 mRNA expression with relapse free survival was analyzed by the Kaplan-Meier plotter in (A) all patients with breast cancer, and different subtypes of BC, including (B) estrogen receptor-positive (ER-positive), (C) ER-negative, (D) basal-like, (E) Luminal A, (F) Luminal B, (G) lymph node-positive, (H) human epidermal growth factor receptor 2 (Her-2)-negative, and (I) Her-2-positive subtypes.